VideoHIVViral Hepatitis and Liver DiseaseAPACC 2020Crowdsourcing to Decrease Hepatitis StigmaView Video
VideoHIVViral Hepatitis and Liver DiseaseAPACC 2020No Pain, No Gain: Crisis, Resilience, and Winning Trust from SARS to COVID-19 Response in TaiwanView Video
SlidesetHIVViral Hepatitis and Liver DiseaseAPACC 2020What Will It Take to End AIDS in Asia - Adeeba Kamarulzaman, MBBS, FRACP, FAMM, FASc, HonLLD Monash, DPMPView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseAPACC 2020Using Social Networks in HIV Research - Weiming Tang,PhD, MD, MSView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseAPACC 2020Weight Gain and Antiretroviral Therapy: What’s Going On, and What Should We Do? - Paul Sax, MDView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseAPACC 2020Universal Coverage of PrEP in Thailand -Taweesap Siraprapasiri, MD, MPHView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseAPACC 2020Towards a Diagnostic-driven Approach to Prevention of HIV-associated Invasive Mycoses in SE Asia -Thuy Le, MD, DPhilView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseAPACC 2020Grant Workshop 101: Reviewer's view - Joseph Tucher, MD, PhD, AMView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseAPACC 2020TB Therapeutic Strategies -Nicholas Paton, MD, FRCPView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseAPACC 2020Prevalence of Anxiety or Depression and Its Associated Factors Among People Living with HIV in Guangzhou During the COVID-19 Outbreak- Linghua Li, MD, PhDView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseAPACC 2020PrEP, Chemsex, and STIs -Stephane Wen-Wei Ku, MDView Slideset
